Psychiatry News: High Cost of Nondisclosure

Legislation is needed to ensure that conflicts of interest rules in medicine are enforced. One method for reigning in the abuse is to prohibit government grant awards to any researcher who violates financial conflict of interest rules.

Continue reading →

NIMH Chief Child/Adoles Research Blows Wind out TeenScreen Sails_ Los Angeles Times

"Some politicians, public health officials, mental health activists and pharmaceutical companies have worked to establish mental-health screening programs in schools and the community….Researchers and clinicians, meanwhile, say they are far from having developed accurate predictors of a child developing depression. The younger the child, the murkier the crystal ball." Continue reading →

Industry Influence: FDA “Critical Path”/ Biased Research: BMJ / NIH: still smoke & mirrors

The battle lines were drawn between those who recognize the corrosive effect that the pharmaceutical industry is having on the safety and integrity of medicine and medical research, and the powerful stakeholders–the pharmaceutical-academic industrial complex. Continue reading →

2 letters Re: Dr. Nemeroff Failure to Disclose Conflicts of Interest_WSJ

Success in academic psychiatry is not measured in the improvement of patients' mental health, but rather in quantifiable commercial tender.How many grants one brings to the university, how many publications one churns out each year, and how many corporate and professional advisory . . . Continue reading →

THE SCIENTIST–Former Head of UK Psychopharmacology says Money Didn’t Sway Dr. Nemeroff

A follow-up to news reports about the conflict of interest scandal that has engulfed not only Dr. Charles Nemeroff, former president and editor in chief of the official journal of the American College of Neuropsychopharmacology, but the College itself.
Continue reading →